跳至主要内容
临床试验/EUCTR2020-005524-11-CZ
EUCTR2020-005524-11-CZ进行中(未招募)1 期

Pilot, monocentre, phase-IV clnical trial assessing the clinical effect of per oral immunomodulation treatment using the IMUNOR® preparation in the prevention of COVID-19 disease

Fakultní nemocnice Ostrava0 个研究点目标入组 100 人开始时间: 2020年12月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - male/female/all sexes
  • - 18-65 years of age
  • - ability to sign the Informed Consent Form
  • - negative pregnancy test
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 90
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • - use of another immunomodulation treatment in the course of one month prior to enrolment into the study
  • - patients with current, insufficiently controlled cardiac, metabolic, endocrinology, hepatal, renal, neurological or psychiatric disease
  • - known hypersensitivity to the medicinal substance
  • - pregnancy and breasfeeding

研究者

相似试验

已完成
4 期
A Phase IV, monocentric, clinical trial to evaluate and compare the number of nicks and cuts among three different shaving systems on healthy Indian men.
CTRI/2011/07/001890Procter and Gamble50
进行中(未招募)
1 期
A clinical trial to evaluate the efficacy and safety of PLACENTEX ¿ administered intra-muscular in patients with cutaneous lesions in scleroderma diseases.Fibrotic and atrophic cutaneous lesions in localized scleroderma diseases.MedDRA version: 20.0Level: HLTClassification code 10039711Term: Scleroderma and associated disordersSystem Organ Class: 100000004870
EUCTR2015-005100-28-ITMASTELLI SR45
进行中(未招募)
不适用
Pilot, open, multicenter, phase IV Clinical Trial to evaluate safety and efficacy in treatment with peginterferon alfa-2a plus ribavirin in VIH patients with advanced immunosupression and chronic hepatopathy secondary to hepatitis C virus. - Treatment with PEG-IFN alfa 2a plus RBV in VIH patients with advanced immunosupression & hepatopathy¨Hepatitis C Crónica
EUCTR2005-002452-17-ESHospital Universitario de Valme
进行中(未招募)
不适用
Study about the high flow and conventional oxigen therapy in patients with severe acute respiratory failure.
EUCTR2012-001671-36-ESFundación para la Investigación Biomédica
进行中(未招募)
1 期
A phase IV, unicentric, open label clinical trial to evaluate the default mode network in multiple sclerosis patients on Cladribine treatmentMedDRA version: 20.1Level: PTClassification code: 10028245Term: Multiple sclerosis Class: 100000004852Multiple Sclerosis
CTIS2023-504577-21-00María Luisa Martínez Ginés20